Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.03 USD
Change Today -0.035 / -1.70%
Volume 449.9K
As of 2:36 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Keith R. Gollust

Executive Chairman, Chairman of Nominating & Governance Committee, Chairman of Executive Committee, Member of Audit Committee and Member of Compensation Committee,Synta Pharmaceuticals Corp.
AgeTotal Calculated CompensationThis person is connected to 46 board members in 4 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Keith R. Gollust served as a Founding Partner at Gollust, Tierney and Oliver. Mr. Gollust has been an Executive Chairman of Synta Pharmaceuticals Corp. since September 2002. He serves as the Chairman of the Advisory Council of the Princeton University Department of Astrophysics. Mr. Gollust serves as a Director of Archimedes Technology and The Juilliard School and a Member of the Advisory Board at Blackstone Alternative Asset Management. He has been a Director at ...

Read Full Background

Corporate Headquarters*

45 Hartwell Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-274-8200
Fax: 781-274-8228

Board Members Memberships*

Executive Chairman, Chairman of Nominating & Governance Committee, Chairman of Executive Committee, Member of Audit Committee and Member of Compensation Committee


Unknown/Other Education
Carnegie Mellon University
Princeton University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options29,000
Unexercisable Options7,250
Total Number of Options36,250

Total Compensation*

Total Annual Cash Compensation$6,000
Total Calculated Compensation$134,529
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNTA:US $2.03 USD -0.035


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNTA PHARMACEUTICALS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at